Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Roncalli

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Cancer Immunology Research|February 6, 2020
Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1<sup>+</sup> CellsNina Cortese, Giovanni Capretti, Marialuisa Barbagallo, et al.
Oncology Reports|April 22, 2008
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastasesIsabella Castellano, Anna Sapino, Riccardo Arisio, et al.
Cell|February 14, 2015
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancerEduardo Bonavita, Stefania Gentile, Marcello Rubino, et al.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
JCI Insight|November 6, 2019
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancerJoanna Mikulak, Ferdinando Oriolo, Elena Bruni, et al.
Science Translational Medicine|September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximabKimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Hepatology (Baltimore, Md.)|January 24, 2018
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentationElizabeth Brunt, Shinichi Aishima, Pierre-Alain Clavien, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Cancer Immunology Research|February 6, 2020
Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1<sup>+</sup> CellsNina Cortese, Giovanni Capretti, Marialuisa Barbagallo, et al.
Oncology Reports|April 22, 2008
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastasesIsabella Castellano, Anna Sapino, Riccardo Arisio, et al.
Cell|February 14, 2015
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancerEduardo Bonavita, Stefania Gentile, Marcello Rubino, et al.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
JCI Insight|November 6, 2019
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancerJoanna Mikulak, Ferdinando Oriolo, Elena Bruni, et al.
Science Translational Medicine|September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximabKimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Hepatology (Baltimore, Md.)|January 24, 2018
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentationElizabeth Brunt, Shinichi Aishima, Pierre-Alain Clavien, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Pageof 15